Last reviewed · How we verify
Charcoal
At a glance
| Generic name | Charcoal |
|---|---|
| Sponsor | Sanofi |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis (PHASE3)
- Activated CHARcoal in Poisoned Patient - Pilot Trial (PHASE4)
- Evaluation of Bacterial Contamination and Antimicrobial Efficacy on Charcoal-Infused vs, Standard Nylon Toothbrush Bristles. (NA)
- Cigarette Filter Study (NA)
- Combined Gastrointestinal Decontamination in Acute Severe Poisoning (PHASE2)
- Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects (PHASE1)
- Charcoal Toothbrushes and Bacterial Contamination: a Clinical Trial. (NA)
- Evaluation of the Health Effects of the Air Purifier in Preterm Infants After Discharge (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Charcoal CI brief — competitive landscape report
- Charcoal updates RSS · CI watch RSS
- Sanofi portfolio CI